Vallerie Mclaughlin
Director/Board Member chez CLENE INC.
Fortune : - $ au 31/03/2024
Profil
Vallerie V.
Mclaughlin is currently serving as the Chairman at the American College of Cardiology Foundation.
She is also an Independent Director at Clene Nanomedicine, Inc., Clene, Inc., and the University of Michigan, where she holds the position of Associate Chief Clinical Officer & Professor.
Previously, she served as the Chairman-Trustees Board at the Pulmonary Hypertension Association, Inc. and as the President at Southern Virginia University.
Dr. Mclaughlin obtained her doctorate degree from the Feinberg School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLENE INC
-.--% | 01/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Vallerie Mclaughlin
| Sociétés | Poste | Début |
|---|---|---|
| CLENE INC. | Director/Board Member | 05/08/2021 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director/Board Member | 05/08/2021 |
| University of Michigan | Corporate Officer/Principal | 01/01/2003 |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Chairman | - |
Anciens postes connus de Vallerie Mclaughlin
| Sociétés | Poste | Fin |
|---|---|---|
| Southern Virginia University | President | - |
Pulmonary Hypertension Association, Inc.
 Pulmonary Hypertension Association, Inc. Medical/Nursing ServicesHealth Services The Pulmonary Hypertension Association, Inc. is an organization that focuses on raising awareness and providing support for individuals with pulmonary hypertension. The private company is based in Silver Spring, MD. The company recently announced new dates for their PHA 2024 International PH Conference and Scientific Sessions, which will take place from August 15-18, 2024 at the JW Marriott. | Chairman | - |
Formation de Vallerie Mclaughlin
| Feinberg School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Health Services |
Pulmonary Hypertension Association, Inc.
Pulmonary Hypertension Association, Inc. Medical/Nursing ServicesHealth Services The Pulmonary Hypertension Association, Inc. is an organization that focuses on raising awareness and providing support for individuals with pulmonary hypertension. The private company is based in Silver Spring, MD. The company recently announced new dates for their PHA 2024 International PH Conference and Scientific Sessions, which will take place from August 15-18, 2024 at the JW Marriott. | Health Services |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
